Meloxicam
Product Images NDC 10544-090

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meloxicam (NDC 10544-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (87c6d3e2 7c66 479b Abe8 551cb8913921 01)

FDA Label Image

Table (87c6d3e2 7c66 479b Abe8 551cb8913921 02)

The above text represents a list of generic names and their corresponding trade names for various pain medications. The medications include nonsteroidal anti-inflammatory drugs (NSAIDs) such as Celecoxib, Diclofenac, Etodolac, Ketorolac, and Piroxicam. It also lists Mefenamic Acid, Meloxicam, and Nabumetone, among others. The text includes a note about Vicoprofen containing the same dosage of ibuprofen as over-the-counter NSAIDs and is used for short-term pain relief. It also warns about the risk of heart attack with long-term continuous use of NSAIDs.*

FDA Label Image

Label Graphic- 7.5mg 30s (87c6d3e2 7c66 479b Abe8 551cb8913921 03)

This is a description of a medication called Meloxicam. It comes in tablet form, with each tablet containing 7.5mg of medication. The package contains 30 tablets and is only available with a prescription. The medication should be stored at room temperature and kept out of reach of children. The package insert should be consulted for dosage instructions. The company that produces this medication is Bonpeim Pharmaceutical, Inc. The product contains the FDA National Drug Code number 10544-030-30. The lot number and expiration date are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.